Standard BioTools Inc. (LAB)

USD 1.99

(-10.18%)

Total Assets Summary of Standard BioTools Inc.

  • Standard BioTools Inc.'s latest annual total assets in 2023 was 323.06 Million USD , down -17.23% from previous year.
  • Standard BioTools Inc.'s latest quarterly total assets in 2024 Q2 was 708.73 Million USD , down -8.86% from previous quarter.
  • Standard BioTools Inc. reported annual total assets of 390.31 Million USD in 2022, up 41.82% from previous year.
  • Standard BioTools Inc. reported annual total assets of 275.21 Million USD in 2021, down -15.26% from previous year.
  • Standard BioTools Inc. reported quarterly total assets of 681.53 Million USD for 2024 Q3, down -3.84% from previous quarter.
  • Standard BioTools Inc. reported quarterly total assets of 777.66 Million USD for 2024 Q1, up 140.71% from previous quarter.

Annual Total Assets Chart of Standard BioTools Inc. (2023 - 2001)

Historical Annual Total Assets of Standard BioTools Inc. (2023 - 2001)

Year Total Assets Total Assets Growth
2023 323.06 Million USD -17.23%
2022 390.31 Million USD 41.82%
2021 275.21 Million USD -15.26%
2020 324.75 Million USD 22.64%
2019 264.81 Million USD -12.79%
2018 303.64 Million USD 5.67%
2017 287.35 Million USD -6.22%
2016 306.39 Million USD -17.43%
2015 371.06 Million USD -8.96%
2014 407.55 Million USD 248.59%
2013 116.91 Million USD 2.8%
2012 113.73 Million USD 43.37%
2011 79.32 Million USD 219.85%
2010 24.8 Million USD -22.87%
2009 32.15 Million USD -0.62%
2008 32.35 Million USD -40.93%
2007 54.77 Million USD 50.1%
2006 36.49 Million USD 0.0%
2001 - USD 0.0%

Peer Total Assets Comparison of Standard BioTools Inc.

Name Total Assets Total Assets Difference
Bionano Genomics, Inc. 214.4 Million USD -50.681%
Prenetics Global Limited 254.17 Million USD -27.106%
Star Equity Holdings, Inc. 86.97 Million USD -271.452%
CareDx, Inc 484.61 Million USD 33.335%
Exact Sciences Corporation 6.47 Billion USD 95.008%
Exagen Inc. 56.94 Million USD -467.342%
Inotiv, Inc. 856.53 Million USD 62.282%
Guardant Health, Inc. 1.78 Billion USD 81.915%
Biodesix, Inc. 99.09 Million USD -226.014%
BioNexus Gene Lab Corp. 11.39 Million USD -2733.973%
Precipio, Inc. 18.1 Million USD -1684.802%
iSpecimen Inc. 15.81 Million USD -1942.254%
Natera, Inc. 1.45 Billion USD 77.828%
Aspira Women's Health Inc. 6.26 Million USD -5059.166%
23andMe Holding Co. 395.16 Million USD 18.245%
Castle Biosciences, Inc. 477.81 Million USD 32.386%
Personalis, Inc. 225.09 Million USD -43.522%
Aclaris Therapeutics, Inc. 197.4 Million USD -63.657%
Applied DNA Sciences, Inc. 13.65 Million USD -2266.518%
OpGen, Inc. 1.88 Million USD -17063.654%
T2 Biosystems, Inc. 34.79 Million USD -828.433%
Myriad Genetics, Inc. 1.19 Billion USD 73.049%
ICON Public Limited Company 16.98 Billion USD 98.098%
NeoGenomics, Inc. 1.68 Billion USD 80.784%
Star Equity Holdings, Inc. 86.97 Million USD -271.452%
IDEXX Laboratories, Inc. 3.25 Billion USD 90.09%
RadNet, Inc. 2.88 Billion USD 88.808%
MDxHealth SA 129.13 Million USD -150.184%
Psychemedics Corporation 13.27 Million USD -2334.567%
Illumina, Inc. 10.11 Billion USD 96.805%
Check-Cap Ltd. 25.01 Million USD -1191.39%
Twist Bioscience Corporation 776.4 Million USD 58.389%
DarioHealth Corp. 96.38 Million USD -235.17%
Fulgent Genetics, Inc. 1.27 Billion USD 74.624%
Sera Prognostics, Inc. 95.44 Million USD -238.499%
ENDRA Life Sciences Inc. 6.75 Million USD -4683.24%
OPKO Health, Inc. 2.01 Billion USD 83.941%
Medpace Holdings, Inc. 1.65 Billion USD 80.501%
Neogen Corporation 4.58 Billion USD 92.953%
Intelligent Bio Solutions Inc. 13.77 Million USD -2244.656%
Prenetics Global Limited 254.17 Million USD -27.106%
Mainz Biomed B.V. 15.4 Million USD -1996.609%
bioAffinity Technologies, Inc. 8.22 Million USD -3829.514%
Trinity Biotech plc 59.43 Million USD -443.564%
Neuronetics, Inc. 115.83 Million USD -178.912%
Sotera Health Company 3.13 Billion USD 89.68%
bioAffinity Technologies, Inc. 8.22 Million USD -3829.514%